Cargando…
Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology
BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. ME...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251918/ https://www.ncbi.nlm.nih.gov/pubmed/35787707 http://dx.doi.org/10.1186/s12958-022-00961-y |
_version_ | 1784740140686508032 |
---|---|
author | Hager, Marlene Ott, Johannes Marschalek, Julian Marschalek, Marie-Louise Kinsky, Clemens Marculescu, Rodrig Dewailly, Didier |
author_facet | Hager, Marlene Ott, Johannes Marschalek, Julian Marschalek, Marie-Louise Kinsky, Clemens Marculescu, Rodrig Dewailly, Didier |
author_sort | Hager, Marlene |
collection | PubMed |
description | BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. METHODS: In a retrospective observational study, 64 women with FHA who underwent a GnRH stimulation test and 32 age-matched controls without PCOM were included. Pulsatile GnRH treatment was provided to 31 FHA patients and three-month follow-up data were available for 19 of these. RESULTS: Serum levels of gonadotropins and estradiol were lower in FHA women than in controls (p < 0.05). FHA patients revealed PCOM in 27/64 cases (42.2%). FHA patients without PCOM revealed lower anti-Müllerian hormone (AMH) levels than controls (median 2.03 ng/mL, IQR 1.40–2.50, versus 3.08 ng/mL, IQR 2.24–4.10, respectively, p < 0.001). Comparing FHA patients with and without PCOM, the latter revealed lower AMH levels, a lower median LH increase after the GnRH stimulation test (240.0%, IQR 186.4–370.0, versus 604.9%, IQR 360.0–1122.0; p < 0.001) as well as, contrary to patients with PCOM, a significant increase in AMH after three months of successful pulsatile GnRH treatment (median 1.69 ng/mL at baseline versus 2.02 ng/mL after three months of treatment; p = 0.002). CONCLUSIONS: In women with FHA without PCOM, the phenomenon of low AMH levels seems to be based on relative gonadotropin deficiency rather than diminished ovarian reserve. AMH tended to rise after three months of pulsatile GnRH treatment. The differences found between patients with and without PCOM suggest the former the existence of some PCOS-specific systemic and/or intra-ovarian abnormalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-022-00961-y. |
format | Online Article Text |
id | pubmed-9251918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92519182022-07-05 Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology Hager, Marlene Ott, Johannes Marschalek, Julian Marschalek, Marie-Louise Kinsky, Clemens Marculescu, Rodrig Dewailly, Didier Reprod Biol Endocrinol Research BACKGROUND: To evaluate in women with functional hypothalamic amenorrhea (FHA), whether there is a difference between patients with and without polycystic ovarian morphology (PCOM) concerning the response to a gonadotropin releasing hormone (GnRH) stimulation test and to pulsatile GnRH treatment. METHODS: In a retrospective observational study, 64 women with FHA who underwent a GnRH stimulation test and 32 age-matched controls without PCOM were included. Pulsatile GnRH treatment was provided to 31 FHA patients and three-month follow-up data were available for 19 of these. RESULTS: Serum levels of gonadotropins and estradiol were lower in FHA women than in controls (p < 0.05). FHA patients revealed PCOM in 27/64 cases (42.2%). FHA patients without PCOM revealed lower anti-Müllerian hormone (AMH) levels than controls (median 2.03 ng/mL, IQR 1.40–2.50, versus 3.08 ng/mL, IQR 2.24–4.10, respectively, p < 0.001). Comparing FHA patients with and without PCOM, the latter revealed lower AMH levels, a lower median LH increase after the GnRH stimulation test (240.0%, IQR 186.4–370.0, versus 604.9%, IQR 360.0–1122.0; p < 0.001) as well as, contrary to patients with PCOM, a significant increase in AMH after three months of successful pulsatile GnRH treatment (median 1.69 ng/mL at baseline versus 2.02 ng/mL after three months of treatment; p = 0.002). CONCLUSIONS: In women with FHA without PCOM, the phenomenon of low AMH levels seems to be based on relative gonadotropin deficiency rather than diminished ovarian reserve. AMH tended to rise after three months of pulsatile GnRH treatment. The differences found between patients with and without PCOM suggest the former the existence of some PCOS-specific systemic and/or intra-ovarian abnormalities. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12958-022-00961-y. BioMed Central 2022-07-04 /pmc/articles/PMC9251918/ /pubmed/35787707 http://dx.doi.org/10.1186/s12958-022-00961-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Hager, Marlene Ott, Johannes Marschalek, Julian Marschalek, Marie-Louise Kinsky, Clemens Marculescu, Rodrig Dewailly, Didier Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title | Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title_full | Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title_fullStr | Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title_full_unstemmed | Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title_short | Basal and dynamic relationships between serum anti-Müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
title_sort | basal and dynamic relationships between serum anti-müllerian hormone and gonadotropins in patients with functional hypothalamic amenorrhea, with or without polycystic ovarian morphology |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251918/ https://www.ncbi.nlm.nih.gov/pubmed/35787707 http://dx.doi.org/10.1186/s12958-022-00961-y |
work_keys_str_mv | AT hagermarlene basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT ottjohannes basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT marschalekjulian basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT marschalekmarielouise basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT kinskyclemens basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT marculescurodrig basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology AT dewaillydidier basalanddynamicrelationshipsbetweenserumantimullerianhormoneandgonadotropinsinpatientswithfunctionalhypothalamicamenorrheawithorwithoutpolycysticovarianmorphology |